Xiaobo Wang

5.3k total citations
42 papers, 534 citations indexed

About

Xiaobo Wang is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Xiaobo Wang has authored 42 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Xiaobo Wang's work include Radiopharmaceutical Chemistry and Applications (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Medical Imaging Techniques and Applications (3 papers). Xiaobo Wang is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Medical Imaging Techniques and Applications (3 papers). Xiaobo Wang collaborates with scholars based in China, United States and Austria. Xiaobo Wang's co-authors include Wenbin Zeng, Gang Liu, Xiaohong Chen, Henry S. Eden, Pengfei Xu, Qingge Li, Xiao Yun Xu, Josephine M. Atienza, Naichen Yu and Yama Abassi and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and The FASEB Journal.

In The Last Decade

Xiaobo Wang

34 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobo Wang China 13 200 123 99 94 54 42 534
Junying Zheng United States 17 262 1.3× 74 0.6× 34 0.3× 77 0.8× 55 1.0× 28 625
Eric Ueda United States 13 440 2.2× 114 0.9× 82 0.8× 85 0.9× 40 0.7× 18 691
Na Qu China 14 365 1.8× 39 0.3× 94 0.9× 92 1.0× 63 1.2× 56 754
Sergio Occhipinti Italy 15 316 1.6× 31 0.3× 133 1.3× 94 1.0× 125 2.3× 32 694
Liqin Zheng China 15 172 0.9× 92 0.7× 340 3.4× 86 0.9× 15 0.3× 59 774
Puja Panwar Hazari India 17 227 1.1× 315 2.6× 139 1.4× 72 0.8× 13 0.2× 70 826
Izumi O. Umeda Japan 15 223 1.1× 176 1.4× 124 1.3× 90 1.0× 37 0.7× 52 620
Buyun Ma China 13 166 0.8× 101 0.8× 184 1.9× 44 0.5× 25 0.5× 39 763
Xinyi Huang China 12 422 2.1× 41 0.3× 51 0.5× 107 1.1× 47 0.9× 37 826
Hyemi Kim South Korea 12 149 0.7× 41 0.3× 70 0.7× 25 0.3× 49 0.9× 38 508

Countries citing papers authored by Xiaobo Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaobo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Wang more than expected).

Fields of papers citing papers by Xiaobo Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Wang. The network helps show where Xiaobo Wang may publish in the future.

Co-authorship network of co-authors of Xiaobo Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobo Wang. A scholar is included among the top collaborators of Xiaobo Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobo Wang. Xiaobo Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaobo, Jianyang Fang, Fei Kang, et al.. (2025). Exploration of Bicyclic Peptide Ligands for Immune-Specific PET Imaging: Targeting Tumor PD-L1 with [18F]AlF-BCY10959. Molecular Pharmaceutics. 22(6). 3456–3467. 1 indexed citations
2.
Zhuge, Zhengbing, et al.. (2025). Association between the oxidative balance score and testosterone deficiency in males: a cross-sectional study. Frontiers in Nutrition. 12. 1577823–1577823.
3.
Chen, Xi, et al.. (2025). Cyclin-dependent kinase 1 (CDK1) in cancers: from upstream regulation to downstream substrates and therapeutic inhibitors. European Journal of Medicinal Chemistry. 299. 118090–118090.
4.
5.
Zhou, Ming, Bei Chen, Chenxi Lu, et al.. (2024). ImmunoPET imaging of LAG-3 expression in tumor microenvironment with 68Ga-labelled cyclic peptides tracers: from bench to bedside. Journal for ImmunoTherapy of Cancer. 12(7). e009153–e009153. 4 indexed citations
6.
Fang, Jianyang, Xiaobo Wang, Lingxin Meng, et al.. (2024). Preclinical Evaluation of 131I/18F-Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging. ACS Pharmacology & Translational Science. 7(6). 1783–1794. 3 indexed citations
7.
Li, Xian‐Fang, et al.. (2024). Real-time Video Target Tracking Algorithm Utilizing Convolutional Neural Networks (CNN). 847–851. 4 indexed citations
8.
Zuo, Xiaohua, Xiaofei Zhang, Xiangyi Deng, et al.. (2023). MOFs-derived CuO–Fe3O4@C with abundant oxygen vacancies and strong Cu–Fe interaction for deep mineralization of bisphenol A. Environmental Research. 228. 115847–115847. 35 indexed citations
9.
Lu, Lan, Jingya Wang, Jie Zhu, et al.. (2023). Plant‐derived virulence arresting drugs as novel antimicrobial agents: Discovery, perspective, and challenges in clinical use. Phytotherapy Research. 38(2). 727–754. 8 indexed citations
10.
Fang, Jianyang, Lingxin Meng, Xiaobo Wang, et al.. (2022). A novel 18F-labeled agonist for PET imaging of stimulator of interferon gene expression in tumor-bearing mice. European Journal of Nuclear Medicine and Molecular Imaging. 50(1). 27–37. 12 indexed citations
11.
Zhou, Ming, Xiaobo Wang, Bei Chen, et al.. (2022). Preclinical and first-in-human evaluation of 18F-labeled D-peptide antagonist for PD-L1 status imaging with PET. European Journal of Nuclear Medicine and Molecular Imaging. 49(13). 4312–4324. 35 indexed citations
12.
Chen, Guirong, et al.. (2022). The interaction of MD-2 with small molecules in huanglian jiedu decoction play a critical role in the treatment of sepsis. Frontiers in Pharmacology. 13. 947095–947095. 7 indexed citations
13.
Wang, Xiaobo, Ming Zhou, Bei Chen, et al.. (2022). Preclinical and exploratory human studies of novel 68Ga-labeled D-peptide antagonist for PET imaging of TIGIT expression in cancers. European Journal of Nuclear Medicine and Molecular Imaging. 49(8). 2584–2594. 29 indexed citations
14.
15.
Wang, Xiaobo, et al.. (2017). Deep Person Re-Identification with Improved Embedding.. arXiv (Cornell University). 5 indexed citations
16.
17.
Liu, Zhiguo, et al.. (2016). Integrin (?v?3) Targeted RGD Peptide Based Probe for Cancer Optical Imaging. Current Protein and Peptide Science. 17(6). 570–581. 17 indexed citations
18.
Tang, Min, Xinxian Weng, Lifang Yang, et al.. (2015). Evaluation of a dansyl-based amino acid DNSBA as an imaging probe for apoptosis detection. APOPTOSIS. 20(3). 410–420. 4 indexed citations
19.
Zhang, Xueyan, et al.. (2014). Observation on intravitreal injection of ranibizumab combined with laser photocoagulation for the treatment of macular edema in BRVO. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Zhou, Ming, et al.. (2014). Advances of Molecular Imaging Probes for the Diagnosis of Alzheimer's Disease. Current Alzheimer Research. 11(3). 221–231. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junying Zheng Breakdown of academic impact, for papers by Eric Ueda Breakdown of academic impact, for papers by Na Qu Breakdown of academic impact, for papers by Sergio Occhipinti Breakdown of academic impact, for papers by Liqin Zheng Breakdown of academic impact, for papers by Puja Panwar Hazari Breakdown of academic impact, for papers by Izumi O. Umeda Breakdown of academic impact, for papers by Buyun Ma Breakdown of academic impact, for papers by Xinyi Huang Breakdown of academic impact, for papers by Hyemi Kim
Rankless by CCL
2026